{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:57:35Z","timestamp":1781308655432,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128450","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:06:55Z","timestamp":1775812015000},"page":"128450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Missed opportunities for herpes zoster vaccination among older adults in the United States"],"prefix":"10.1016","volume":"79","author":[{"given":"Justin","family":"Gatwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Stempniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128450_bb0005","series-title":"National Health Interview Survey, 2022","article-title":"Vaccination coverage among adults in the United States","author":"Hung","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128450_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128450_bb0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128450_bb0025","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128450_bb0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128450_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128450_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100397","article-title":"Efficacy and safety of the recombinant zoster vaccine: a systematic review and meta-analysis","volume":"15","author":"Zeevaert","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2026.128450_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103241","article-title":"Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications","volume":"83","author":"Strezova","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2026.128450_bb0060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s41669-021-00262-x","article-title":"State-level variations and factors associated with adult vaccination coverage: a multilevel modeling approach","volume":"5","author":"Garbinsky","year":"2021","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.vaccine.2026.128450_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/21645515.2017.1403697","article-title":"An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability","volume":"14","author":"La","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128450_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.36469\/jheor.2025.140817","article-title":"Characteristics, treatment patterns, healthcare resource utilization, and costs among patients with multifocal motor neuropathy: a US claims database cohort study","volume":"12","author":"Khandelwal","year":"2025","journal-title":"J Health Econ Outcomes Res"},{"key":"10.1016\/j.vaccine.2026.128450_bb0075","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3201\/eid2608.191493","article-title":"Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States","volume":"26","author":"Patel","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128450_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","article-title":"Incidence of herpes zoster in patients with altered immune function","volume":"42","author":"Chen","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2026.128450_bb0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128450_bb0100","unstructured":"Health Resources and Services Administration. Health workforce data, tools, and dashboards. https:\/\/data.hrsa.gov\/topics\/health-workforce\/health-workforce-shortage-areas; 2025. [Accessed 7 January 2026]."},{"key":"10.1016\/j.vaccine.2026.128450_bb0105","unstructured":"Environmental Systems Research Institute. An overview of the spatial statistics toolbox, https:\/\/pro.arcgis.com\/en\/pro-app\/latest\/tool-reference\/spatial-statistics\/an-overview-of-the-spatial-statistics-toolbox.htm; [accessed January 20, 2026]."},{"key":"10.1016\/j.vaccine.2026.128450_bb0130","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.vaccine.2023.04.067","article-title":"Recombinant zoster vaccine coverage in the United States: an analysis of claims-based data","volume":"41","author":"Lewis","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128450_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70301","article-title":"National trends and disparities in herpes zoster vaccination among US older adults with diabetes, 2008-2023","volume":"34","author":"Hung","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2026.128450_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127326","article-title":"National trends and disparities in herpes zoster vaccination coverage among U.S. older adults with cancer, 2008-2023","volume":"60","author":"Hung","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128450_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126537","article-title":"Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage","volume":"43","author":"Tsai","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128450_bb0150","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.amepre.2016.08.029","article-title":"Herpes zoster vaccine coverage in older adults in the U.S., 2007-2013","volume":"52","author":"Zhang","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2026.128450_bb0155","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.amepre.2015.03.005","article-title":"Racial and ethnic disparities in vaccination coverage among adult populations in the U.S","volume":"49","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2026.128450_bb0160","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/21645515.2019.1660119","article-title":"The pharmacist and pharmacy have evolved to become more than the corner drugstore: a win for vaccinations and public health","volume":"16","author":"Shen","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128450_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14760584.2024.2441255","article-title":"Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018-2024: a database study","volume":"24","author":"Zheng","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128450_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/phrs.2024.1606679","article-title":"Unraveling herpes zoster vaccine hesitancy, acceptance, and its predictors: insights from a scoping review","volume":"45","author":"Wang","year":"2024","journal-title":"Public Health Rev"},{"key":"10.1016\/j.vaccine.2026.128450_bb0180","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40121-019-00269-2","article-title":"A community-based survey to assess knowledge, attitudes, beliefs and practices regarding herpes zoster in an urban setting","volume":"8","author":"Baalbaki","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.128450_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2157164","article-title":"A review of factors influencing vaccination policies and programs for older adults globally","volume":"19","author":"Eiden","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128450_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vaccine.2022.10.076","article-title":"Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States","volume":"41","author":"Fix","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128450_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/pop.2023.0284","article-title":"Knowledge, attitudes, and practices regarding herpes zoster vaccination among specialists","volume":"27","author":"Singer","year":"2024","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.vaccine.2026.128450_bb0210","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2488093","article-title":"Herpes zoster vaccination: primary care provider knowledge, attitudes, and practices","volume":"21","author":"Stempniewicz","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128450_bb0215","series-title":"The IRA expanded access to adult immunization, but there are opportunities to do more, Doi: 10.1377\/forefront.20231113.205660; [accessed January 18, 2026]","author":"Fix","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128450_bb0225","article-title":"Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review","volume":"82","author":"Wennekes","year":"2024","journal-title":"Arch Public Health"},{"key":"10.1016\/j.vaccine.2026.128450_bb0230","doi-asserted-by":"crossref","unstructured":"Rezahosseini O, Bazargan A, Eiberg MF, Korsgaard AP, Niyati R, Ekenberg C, Nielsen LN, Harboe ZB. Safety and immunogenicity of co-administration of herpes zoster vaccines with other vaccines in adults: a systematic review and meta-analysis. Vaccines (Basel) 2025;13. Doi: https:\/\/doi.org\/10.3390\/vaccines13060637.","DOI":"10.3390\/vaccines13060637"},{"key":"10.1016\/j.vaccine.2026.128450_bb0240","article-title":"Role of new vaccinators\/pharmacists in life-course vaccination","volume":"56","author":"Doherty","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.vaccine.2026.128450_bb0250","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/19427891251392576","article-title":"Disparities in recombinant zoster vaccine coverage in the United States","volume":"28","author":"Singer","year":"2025","journal-title":"Popul Health Manag"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:47:23Z","timestamp":1781308043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"alternative-id":["S0264410X26002586"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128450","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Missed opportunities for herpes zoster vaccination among older adults in the United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 GSK plc.. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128450"}}